Arnon, Tadmor-Levy advises hospitals and a broad range of healthcare and life sciences companies, including pharmaceutical, biotechnology, medical device and digital health clients. The practice covers healthcare-related AI, strategic collaborations, clinical trials, regulatory compliance, investments and M&A, as well as privacy and data protection, corporate governance, hospital–insurer arrangements, IVF regulation, and cloud-based healthcare systems. Barry Levenfeld handles life sciences-related IP transactions, including strategic partnering and licensing; Daniel Green acts for technology transfer organisations at universities and medical centers; and Efrat Shapira-Orren is ‘one of a kind’. Yoheved Novogroder Shoshan and Miriam Friedmann are other experienced practitioners.
Healthcare and life sciences in Israel
Arnon, Tadmor-Levy
Weitere Kernanwälte:
Barry Levenfeld; Daniel Green; Efrat Shapira-Orren; Yoheved Novogroder Shoshan; Miriam Friedmann; Avital Bruker-Yamin; Avi Farchi; Asaf Tenenbaum
Referenzen
‘An extremely professional and knowledgeable team.’
‘Smart and sophisticated lawyers, with great business understanding, and very thorough and responsive.’
‘Efrat Shapira-Orren is talented and sharp.’
Kernmandanten
Kaneka Corporation
Immunai
4C Biomed
Seagen
ALYN Hospital
Allergan
Alma Lasers Ltd.
Amylyx Pharmaceuticals
Append Medical
Samson Assuta Ashdod Public University Hospital (Registered Nonprofit)
Assuta Medical Centers
Barclays Capital
BeWeld Medical
Bio-Change
Bio Refine
BioLineRx
Bioventus
Boston Scientific
BSense
CatchMe Therapeutics
Endomatic
FutuRx
Genmab A/S
Hedonia
Heracure Medical
Immunogen
Incentive Incubator
Integra Holdings
Lifecord
Medison Pharma Group
MEDX XELERATOR
On-Sight Medical
Oramed Pharmaceuticals
Patho-Lab Diagnostics
Pocared Diagnostics
Premia Spine
Prilenia Therapeutics
RMDY Health
SAREL Supplies & Services for Medicine
Simplificare
Sinusafe Medical
Sirvir
Skip Therapeutics
Stryker Corporation
Supercede Therapeutics
Super Spectra
Swift Duct
Veinway
Nectin Therapeutics
Highlight-Mandate
- Advising Assuta Medical Centers on IVF incidents, regulation, digital innovation, and hospital operations.
- Advising Oramed Pharmaceuticals on a $150m joint venture with HTIT for the global commercialisation of oral insulin.
- Advising Alcon Pharmaceuticals on both the acquisition of Belkin Vision and an option to purchase Azura Ophthalmics.
FISCHER (FBC & Co.)
FISCHER (FBC & Co.)‘s client base comprises pharmaceutical, biotechnology, medical device and diagnostic companies, along with medical institutions and non-profit organisations. The healthcare and life sciences team covers technology transfers, IP licensing, regulatory compliance, and data privacy and protection, as well as M&A, dispute resolution and competition law. Raz Tepper has significant expertise in international life sciences-related transactions; Eran Yaniv‘s practice includes technology licensing and research and development work; and Sharon Gazit ‘tailors solutions and advice that are impactful’. Other names to note are Yoram Bonen, Judy Amidor and Lennie Zivoni.
Praxisleiter:
Raz Tepper; Eran Yaniv; Sharon Gazit
Weitere Kernanwälte:
Yoram Bonen; Judy Amidor; Lennie Zivoni; Warren Wienburg; Tal Wiesengrun
Referenzen
‘Deep understanding of the biotech start-up industry in all its aspects.’
‘Knowledge of the nature of contracts, industry standards, deal structures, and day-to-day Pharma contracting.’
‘Great knowledge and experience.’
Kernmandanten
Kamada
Perrigo Company
Edwards Lifesciences
Astrazeneca Israel
Bristol-Meyers Squibb Company
Medtronic Ventor Technologies
Elgan Pharma
Fisher & Paykel Healthcare Corporation
Purple Biotech
CytoReason
Sofwave Medical
OrbiMed Healthcare Fund
OrbiMed Advisors
Bluewind Medical
PhysioMap
AllMeD Solutions
Baring Private Equity Asia
415 Capital Fund II GmbH & Co
Peregrine Ventures Growth Fund
Peregrine Ventures V Fund
Tarom Innovative Technologies
Starget Pharma
Pitango Venture Capital
Hadassah Medical Organization
The Israeli Medical Association
Alpha-Bio Tech
Medica Excel Tel Aviv
Biotronik SE & Co
Envizion
Truleaf Medical
MetaSight Diagnostics
Virility
Korro AI
CaloSense
MTIP
PhaseV
LTS Medical Devices
Discure Technologies
Baxter International
Eisai Co.
Livia
Vitalgo Systems
Agile MRI
Highlight-Mandate
- Advising US medical device entity Edwards Lifesciences on its acquisitions in Israel.
- Advising global biopharmaceutical company Kamada on life sciences sector regulatory matters.
- Advising Astrazeneca Israel on a variety of matters.
Goldfarb Gross Seligman & Co.
Handling both transactional and regulatory mandates, Goldfarb Gross Seligman & Co. acts for pharmaceutical, medical device, digital health and AI health companies, as well as start-ups, academic technology transfer offices, and research centres. Practice head Hili Cohen routinely advises technology-based life sciences and healthcare companies on day-to-day issues, corporate law, fund raising, strategic partnerships, and M&A, while Danny Kleinhendler acts for healthcare and life sciences clients on cross-border transactions, financings and licensing. The team also features experienced practitioners Shir Shalev and Ofir Goldstein.
Praxisleiter:
Hili Cohen
Weitere Kernanwälte:
Danny Kleinhendler; Shir Shalev; Ofir Goldstein
Kernmandanten
3 Millenium Group
Abbott Laboratories
Accelmed
Acthera Therapeutics
Agada Medical
AISAP
AIVF
Align Technology
Almeda Ventures
American Well
AMG American Medical Genetics
AquafitIntimate
ARDiS
Arkin Holdings
Atricure
BactoByte
Best Brain
BeyondMeat
Bioforum
Biogen
BioMeat FoodTech
BiondVax
BionTech
Biotest
Bpreven
BrainsGate
Brainsway
Breath of Life International
Bunge
Capricon Medical
Cannopiea
Cardiovalve
Carestream Health
CartiHeal
Chemipal
Clal Biotechnologies Industries
ClearSkin
Cochlear
Collplant
Cookin
Covington & Burling
Cronos Group
Curatio Healthcare
Deloitte
Diaper Clean
DriveTech
Edan Materials
EDEN Medical Genomics
Edwards Lifesciences Corporation
eHealth Ventures
Elanco
Elnis Beauty
Endospan
Enveric Biosciences
Enzymit Inc.
Eximo Medical
fUJIFilm
Gero3D
GI View
Gilboa Therapeutics
Grunenthal
Heally Israel
Health Lab Care
Hexa
Human Xtensions
ICL Group
Illingworth Research Group
Igentify
Industrie Biomediche Insubri
InMed
InnoBev
InnovaHealth Partners
Inovytec Medical Solutions
Insightech
Intratech Medical
Invisicare
Invitae
Itamar Medical
Izun Pharma
Keystone Dental
KTR Medical
LifeVantage
Longevity AI
Maccabi Healthcare Services
Madrigal Pharmaceuticals
Magen David Adom In Israel
Magenta Medical
Maveriqx Medical Softwares
Mazor Medical
MDGO
MDI Health Technologies
MDigo
MedCPU
MediMe.
Mediwound
Medtronic
Menorah Insurance Company
Merz Pharma GmbH & Co
Milagro
Mother’s Choice
Movement Wellness
MSD
Nailomatic
Nanocarry Therapeutics
National Insurance Institute of Israel
NeuroSense Therapeutics
Novo Nordisk
Nuar Technologies
OceanTech Acquisitions I Corp
Ohhmed Medical
opticaldiagnostics.com
Orasis
Organigram
Ortho Clinical Diagnostics
Outburn
Petsapien
Pharmaceutical Research Associates
PRA HealthScience
Premier Research
Providence Health & Services
Q-Art
Quest Pharmaceuticals
Rafa Laboratories Co
Rainbow Medical
Rapid Medical
RealView Imaging
Redhill Biopharma
Regeneron Pharmaceuticals
Resilience Accelerator
Respiration Scan
ReWalk Robotics
Rimonim
Rinnerva
Roche Pharmaceuticals (Israel)
SciVac
SeeGene
Sherman Lab
SheRun Labs
SHL Telemedicine
Smarlant
Sol-Gel Technologies
Sonivie
Sonova Holding
Sonova Israel
Sonova USA
Spatz FGIA
Sufresca
Synergio
Taro Pharmaceutical Industries
Technology and Resilience in Community
Telesofia Medical
Temi Global
The Board of Directors of Clalit
The Israeli Medical Association
Therapix Biosciences
Under Pressure
Valcare Medical
Vertex Pharmaceuticals
Vibrant
VitalGo Systems
VRHealth
Well Beat
WellBeat
West Pharmaceutical Services
Wize Pharma
Highlight-Mandate
- Advising medical device company Magenta Medical on its $105m Series E financing round.
- Advising the Special Committee of the Board of Directors of Taro Pharmaceutical Industries on its $671m going private transaction by merger with its controlling shareholder, SUN PHARMA Pharmaceutical Industries.
- Advising Israeli biomed company CartiHeal on its acquisition by international medical device company Smith+Nephew for up to $330m.
Gornitzky & Co.
In January 2025, Gornitzky & Co. merged with life sciences boutique firm Horn & Co, the combination adding expertise in licensing and technology transfers, particularly in the biotech, pharmaceutical and med-tech sectors. Practice head Yuval Horn is a highly-rated expert in licensing, collaboration agreements, technology transfers, clinical trials, and cross-border M&A involving life sciences companies; Shlomo Landress advises on biotech and med-tech sector transactions; and Keren Kanir‘s workload covers transactional and regulatory mandates. The practice further includes Itamar Mei-Zahav, an adviser on licensing deals, university technology transfer agreements, and IP-driven commercial deals.
Praxisleiter:
Yuval Horn
Weitere Kernanwälte:
Shlomo Landress; Keren Kanir; Itamar Mei-Zahav; Oded Uni
Referenzen
‘The experience with the team is outstanding.’
‘The team is very impressive. The associates are responsive, creative, and highly engaged, bringing real energy and insight to every matter.’
‘They understand the pace and pressures of the start-up world and consistently deliver advice that is both technically precise and commercially relevant.’
Kernmandanten
V-Wave
Boston Scientific Corporation
TD Cowen
Guggenheim Securities
Ossio
Lutris Pharma
Aignostics
Theator
Scopio Labs
SurgiAI
E-Health Ventures
Pontifax Venture Capital Funds
MeMed Diagnostics
EdgeMed Ventures
MiCure Therapeutics
Kamari Pharma
Highlight-Mandate
- Acted as Israeli counsel to V-Wave on its sale to Johnson & Johnson for a total consideration of US$1.675 billion.
- Acted as Israeli counsel to Boston on its definitive agreement to acquire SoniVie, a privately-held, med-tech company.
- Advised Lutris Pharma on a financing round of US$30 million, aimed at advancing the clinical development of LUT014.
Herzog Fox & Neeman
Herzog Fox & Neeman‘s clients include global pharmaceutical companies, hospital spinouts and health maintenance organisations (HMOs), as well as insurers, investors and digital health innovators. The team is particularly experienced in regulatory matters, cross-border mandates, and health-tech collaborations and M&A. Dan Sharot advises on the life sciences, medical device and healthcare sectors at every growth stage; Neta Dorfman-Raviv assists HMOs and hospital clients with regulatory matters; and Zohar Yahalom is a former Medical Technologies Administration legal adviser. Orit Hipsher, Anat Gozlan Langberg and Tal Grofi also come recommended.
Praxisleiter:
Neta Dorfman-Raviv; Dan Sharot; Zohar Yahalom; Orit Hipsher
Weitere Kernanwälte:
Anat Gozlan Langberg; Tal Grofi; Lior Lederman
Referenzen
‘Knowledgeable and cooperative.’
‘A true strategic partner. The team is exceptional for its understanding of both the scientific and business aspects of clients’ work, especially in a field that is changing at a very high pace.’
‘They grasp the nuances of biotech R&D and AI platforms, and translate them into practical, forward-looking legal strategy.’
Kernmandanten
Accenture
Adama
AION Innovations Labs
Alpha Omega
Assuta Ashdod
Assuta Medical Centers
Ayrmid
BMC Software
BeeHero
Biotic Circular Technologies
Boston Scientific
Cassidy Bio
Cellyrix Therapeutics
Citibank
Clal Insurance Company
CrossFlow
Cyberark
DeePathology
DenovAI
Gaming Tech
GE Medical Systems Israel
Johnson & Johnson
Insurance Agents Association in Israel
Liveperson
Phoenix Insurance Company
Madanes Insurance Agency
Magen David Adom Association in Israel
Mana.Bio
Medisafe
Merck KGaA
Meuhedet (HMO)
Natural Intelligence
Neogames
Neteera
Novolog
Merck Serono
Eli Lilly Israel
GE HealthCare
Abbvie
Philips Medical
Philips Electronics
Profility
Rambam Hospital
Sahara Medic
Illumina
Impact Bio
Boehringer Ingelheim Israel
TailorMed
TechnoPulm
Teva
The Israel Museum
Trojan Bio
Wolt
Zimmer Biomet
Highlight-Mandate
- Advised Qiagen on its acquisition of GNX Data Systems, a genomics platform, the matter addressing privacy, genetic data and health data reuse issues.
- Advised AION Labs and its AI-driven biotech start-ups on licensing, data sharing, collaborations, financings, and research deals with Big Pharma and academic institutions.
- Advised BioLineRx on an exclusive licence and equity deal with Ayrmid for FDA-approved APHEXDA®, the matter including IP, Innovation Authority grants, sub-licensing, and financing issues.
Lipa Meir & Co
With significant experience in the public and private healthcare sectors, Lipa Meir & Co advises on investments, joint ventures, licensing agreements, and commercial and M&A deals, as well as litigation, class actions and regulatory issues. The practice also acts for cannabis start-ups on commercial and shareholder agreements. Gary Copelovitz advises several domestic and global healthcare clients on corporate and commercial law, particularly cross-border M&A transactions; litigation and dispute resolution practitioner Isaac Anidjer ‘does not give up until he achieves the best result’; and Meir Elbaum‘s clients include hospitals and private clinics.
Praxisleiter:
Gary Copelovitz
Weitere Kernanwälte:
Isaac Anidjer; Meir Elbaum
Referenzen
‘A top-tier firm with excellent lawyers and a high professional standard.’
‘Very in-depth knowledge of the life sciences sector.’
’Israel’s leading firm in the field of healthcare, with unique experience that no other firm possesses.’
Kernmandanten
Hepion Pharmaceuticals
Menorah Mivtachim Insurance Company
Al-Rad Medical
OPTM.RX
Exosomm
BlinkAid
Tengable
AP Partners Fund
Galil Okek Incubator
Biopharma Credit
Clalit Health Services
Lahav CRO
LEM Laboratory for Early Detection
Mor Institute for Medical Data
Mor Inside
Tel Hashomer Hospital
Shila Medical Services
Mor Research Applications
Medtechnica Orthophone
Natural Birth Centre
Tel Bar Industries For Health Institutions
Clalit Biomedical Engineering
Mileutis
Shekel Brainweigh
Harel Insurance Company
BaEmek Technologies
Highlight-Mandate
- Advising Galil Ofek, an Israeli Innovation Authority incubator that supports healthcare and life sciences start-ups in Northern Israel, on a range of corporate and commercial matters.
- Advised NASDAQ-listed Hepion Pharmaceuticals on its successful $58 million merger with Israel-based Pharma Two B.
- Advising Clalit Health Services on ongoing legal matters.
Meitar Law Offices
Meitar Law Offices acts for healthcare institutions, physicians and research institutes’ technology transfer arms. The team’s expertise ranges from IP protection and management, to clinical trials, product liability disputes, financing, and M&A. The team also advises on privacy issues, licensing, commercial agreements, compliance, and strategic collaborations and joint ventures. Haim Gueta advises entrepreneurs, start-ups, and pharmaceutical, biotechnology and medical device companies; technology and IP specialist Boaz Mizrahi is ‘truly in a class of his own’; and Ron Peleg heads the product liability practice. David Shulchani was promoted to partner in January 2025.
Praxisleiter:
Haim Gueta; Boaz Mizrahi; Ron Peleg
Weitere Kernanwälte:
David Shulchani; Gilad Schiff; Rebecca Fisher; Daniel Colthof; Adi Blumenthal Yaari
Referenzen
‘This practice distinguishes itself through a rare fusion of legal excellence, scientific sophistication, and commercial acumen. The team operates at the intersection of law and cutting-edge innovation, with particular strength in IP, biotechnology, and the life sciences.’
‘What sets the group apart is its ability to translate the most complex scientific developments into practical, forward-looking legal strategies that directly advance client objectives.’
‘The team’s capabilities extend far beyond traditional legal advisory work. They combine deep technical knowledge with strategic creativity, consistently delivering solutions that protect innovation while driving commercial growth.’
Kernmandanten
Pfizer
GlaxoSmithKline Research & Development
Integra Lifesciences
Medivators
MediWound
Gamida Cell
Access Industries
Ayala Pharmaceuticals
CaribouBio
Corcept Therapeutics
Senseera
Alive Israel Healthtech Fund
Neura
Mapi Pharma
Equashield Medical
Varay Oncology Systems
Oncohost
PhenoAI
Max Ovary 23
Shempriz Health
AIVF
ActualSignal
Elsmed Health Care Solutions
Aidoc Medical
Barimil
Raptor Bio
Breslauer
Indoma
Canopy Immuno-Therapeutic
MemoryPlus
Grand-App AI
Stem-Cell Medicine
Highlight-Mandate
- Advised Pfizer, as co-lead investor, on CytoReason’s $80 million financing round, which also included participation from OurCrowd, NVIDIA and Thermo Fisher Scientific.
S. Horowitz & Co
S. Horowitz & Co‘s multidisciplinary healthcare and life sciences practice covers the gamut of life sciences matters, from R&D and regulatory approvals to high-value transactions, litigation and market access. Dovev Apel is consistently sought out by global pharmaceutical companies, biotech innovators, and medical device manufacturers; Ran Vogel is a highly-rated patent litigator; and Moti Malca advises life sciences, biotech and hi-tech clients on corporate, commercial, and securities law. The team further includes Tal Band, who assists multinational corporations, academic institutions, and emerging biotechnology ventures with patent, trade mark, and copyright disputes.
Praxisleiter:
Dovev Apel; Ran Vogel
Weitere Kernanwälte:
Moti Malca; Tal Band; Miriam Zaltsman
Referenzen
‘One of the best patent litigation teams in Israel.’
‘Tal Band always goes the extra mile.’
Kernmandanten
Teva Pharmaceutical Industries
Teva Medical
Dexcel
Dexcel Pharma Technologies
Sanofi Aventis
The Chemical, Pharmaceutical and Environmental Society of the Manufacturers’ Association of Israel
Procter and Gamble
Boston Scientific Corporation
Natera
Clever Leaves Holdings
AMI Medical Technologies
Rhenium Medical
NovoCure
Fidelity Investments
Taro Pharmaceutical
KI Research Institute
Weizmann Institute of Science
American Orthodontics
Havat-Da’at Veterinarian Hospital and Emergency Services
Rehovot Veterinary Hospital
AbbVie
Highlight-Mandate
- Represented Teva Pharmaceutical Industries in a motion for preliminary injunction that was submitted by Novartis, regarding Teva’s launch and subsequent commercial activity in Europe concerning Fingolimod.
- Representing Sanofi Aventis in a motion for certification of a class action suit, which concerns information in a consumer medicine leaflet and summary of a product characteristics leaflet.
- Assisting Dexcel and Dexcel Pharma with motions for certification of class actions, in connection with an alleged impurity in pharmaceutical preparations.
Agmon with Tulchinsky Law Firm
Agmon with Tulchinsky Law Firm‘s client base comprises start-ups, hospitals, health maintenance organisations, technology transfer offices, technology incubators, and venture capital funds. Yifat Tsafrir ‘combines sharp legal drafting with a real sense for the business side of healthcare and life sciences’; Lana Tavor advises biotech companies on product development and commercialisation issues; and Uri Barak acts for a range of healthcare and life science companies. Other key figures include Alon Tabak-Aviram, Osnat Sarusi Firstater and Ehud Arad.
Praxisleiter:
Yifat Tsafrir; Alon Tabak-Aviram; Osnat Sarusi Firstater; Uri Barak
Weitere Kernanwälte:
Lana Tavor; Ehud Arad; Asaf Danziger; Dan Smolansky; Karin Abramovich
Referenzen
‘This practice is unique in combining deep legal expertise with strong commercial awareness and a highly client-focused approach.’
‘The team is responsive, practical and proactive, often acting as a natural extension of clients’ business.’
‘Compared to other firms, they stand out for their commitment, solution-oriented mindset, and ability to connect clients with the right stakeholders.’
Kernmandanten
Teva Pharmaceutical Industries
Clalit Healthcare
Shaare Zedek Medical Center
The Association of Friends, Tel Aviv Sourasky Medical Center
SHL Telemedicine
PoLoPo
Ardena Labs
K2Ai
Attias Group
ILM Telemedicine and Logistics Group
Zotal
Supportify
SimHawk
Maxonis
Touchstone International Medical Science Co
Maccabi Pharm
Kupat Holim Meuhedet
Hadassah Ein Kerem Hospital
Livnat Poran
Nuversys
Shaare Zedek Scientific
Cantor Fitzgerald
T- Syte
Virtual Care
Hospitech Respiration
Lifebiotic Medical research
Phebra Pty
Kaizen Bio-Tech
Enzysurge
Reuth Rehabilitation Hospital
Gadot Agro
Minovia
Neuroderm
ConTIPI Medical
Luneau Technology
Haldor
Biond Biologics
RA Capital
Widex
Cadens Orthodontists
Attias Group
Robiotec
Kamada
Kimberly Clark
Merck
Perrigo
Cactus Capital
Novartis
Project Galaxy
Citco – Syneos Health Clinical
PonteX
Synergy7
Revel Technological Solutions
Highlight-Mandate
- Advised Teva on acquiring exclusive licensing rights.
- Advised Kamada on its licensing and distribution agreements with Canadian Blood Services, Pharming in Israel, and Er-Kim in Turkey.
- Advised Biond Biologics on several agreements that enhance its research and development capabilities, including a Research and Collaboration and Option Agreement with Janssen.
Firon Law Firm
Fielding specialists across pharmaceuticals, biotech and healthcare, Firon Law Firm advises global pharmaceutical companies, major hospitals, health maintenance organisations and start-ups on licensing agreements, investment rounds and related regulatory matters. The practice is jointly led by biotech and pharmaceutical sector expert Baruch Shugol, who is ‘a pillar of the healthcare legal community’; and Sivan Narkiss, a specialist in pharmaceutical sector-related regulatory issues. The firm further includes Jacob Enoch, who heads up its M&A and international transactions department.
Praxisleiter:
Baruch Shugol; Sivan Narkiss
Weitere Kernanwälte:
Jacob Enoch
Referenzen
‘A unique and ideal combination of expertise, experience, knowledge and top-notch service.’
’Baruch Shogul – uncommon command of every regulatory aspect. A pillar of the healthcare legal community.’
‘Sivan Narkiss – bright, effective and impressive.’
Kernmandanten
Gilead
Herzliya Medical Centre
Clalit Health Services
Pharma Israel
Sanofi
EMMS Nazareth Hospital
Hadassah Medical
Geffen Mediacl
SLH Medical Services
DMC
Highlight-Mandate
- Acting for Sanofi on an ongoing basis.
- Advising Herzliya Medical centre on various aspects of its operation.
- Advising EMMS Nazareth Hospital on various aspects of its operation.
Liad Whatstein & Co. Law Office
Liad Whatstein & Co. Law Office regularly advises global pharmaceutical companies on high-stakes patent litigation and prosecution, alongside related regulatory and transactional matters. The practice is also noted for its work on life cycle management strategies for major pharmaceutical products, as well as licensing arrangements and broader commercial transactions within the life sciences sector. The team is co-led by renowned IP litigator Liad Whatstein and Amira Mangelus, who acts in life sciences-related patent disputes. Oren Weiner is a patent term extension expert, who assists with pharmaceutical product management issues.
Praxisleiter:
Liad Whatstein; Amira Mangelus
Weitere Kernanwälte:
Oren Weiner
Kernmandanten
Novartis
Sanofi
Merck & Co
Pfizer
Bristol Myers Squibb
Takeda
Regeneron
Abbott
Bayer
Astellas
Alkermes
UCB Pharma
Lundbeck
Leo Pharma
Novo Nordisk
The State of Israel
The Hebrew University
InterMune
Dr Fischer Pharmaceuticals
Harvard University
Immunogen
Advanced Accelerator Applications
Axcella Health
Principia Biopharma
AIC246 AG & Co
ABLYNX NV
Translate Bio
Equilibrate Therapeutics
Disc Medicine
miRecule
Madrigal Pharmaceuticals
Genzyme Corporation
Medigene Immunotherapies
The Research Foundation for the State University Of New York
Sheba Hospital
Vactech Oy
Highlight-Mandate
- Representing Pfizer in patent proceedings with respect to Pfizer’s blockbuster drugs, Nurtec (Rimegepant) and Vyndaqel (Tafamidis), such proceedings involving complex chemistry, formulation technology and drug pharmacokinetics issues.
- Representing Merck in patent proceedings against Halozyme, in relation to the new formulation of Keytruda (anti-cancer drug).
- Acting for the State of Israel in litigation against Teva, which concerns a new version of Copaxone, a drug that is based on technology developed at a government-owned hospital.
Pearl Cohen Zedek Latzer Baratz
Handling patent prosecutions, acquisitions, sales, financings and litigation, Pearl Cohen Zedek Latzer Baratz represents both start-ups and global clients from the pharmaceutical, healthcare, and medical devices sectors. The team’s principal figures are: IP specialist Zeev Pearl and patent prosecution expert Mark S Cohen, who both work between Tel Aviv and New York; Yael Baratz, whose sector experience includes biotechnology; and Hili Rashkovan, an adviser on patent licensing, joint development agreements, technology acquisitions, and clinical trials. Galit Bonet is another name to note.
Praxisleiter:
Zeev Pearl; Mark S Cohen; Yael Baratz; Hili Rashkovan; Galit Bonet
Weitere Kernanwälte:
Inbal Perlstein-Mandelbaum; Ephraim Zachary Heiliczer; Shlomi Arbel; Shir Nahum
Kernmandanten
Bayit Balev
Bayer
Pfizer
Sanofi
Dexcel Pharma
Maccabi Health Services
Biondvax Pharmaceuticals
SciVac
KAHR Medical
Estar Medical
340Basics
Marpai
MyOr Diagnostics
Nobio
QuantalX Neuroscience
GrayMatters Health
Hadasit Medical Research Services and Development
Efrat Assa-Kunik + Yulie Schirer Rom
Lumenis
Highlight-Mandate
- Assisting MyOr Diagnostics with various strategically important cross-border corporate matters, including establishing a joint venture with Nucitec to further both companies’ research.
- Advising Opko Biologics on IP protection and management issues, including helping negotiate and draft licensing agreements.
Shibolet & Co.
Shibolet & Co.‘s multidisciplinary practice assists with the regulatory side to new technologies, medical devices, pharmaceuticals, and healthcare systems. It also covers transactional and commercial matters. Tal Karplus ‘brings exceptional legal knowledge’; Amos Bentzur is a pharmaceutical, medical device and healthcare sector specialist; and Ofer Ben-Yehuda is a technology industry expert. Healthcare, life sciences and pharmaceutical regulation practitioner Nili Hayun Dickman recently joined from the Israeli Ministry of Health, where she was chief legal adviser to the medical technologies division.
Praxisleiter:
Tal Karplus; Amos Bentzur
Weitere Kernanwälte:
Ofer Ben-Yehuda; Nili Hayun Dickman; Einat Weidberg; Rotem Haklay; Adi Issawi; Shani Barad Samuel; Julia Schneiderman
Referenzen
‘This practice combines deep legal expertise with specific experience in the healthcare and life sciences area.’
‘They are client focused, and with a practical approach.’
‘The team is highly responsive, detail oriented, and ensures partner involvement throughout, which sets it apart from other firms.’
Kernmandanten
Eli Lilly
Johnson & Johnson
Roche Pharmaceuticals
Sarepta
Takeda
BD
Molnlycke Health Care
Abbott
Maccabi Health Services HMO
Meuhedet HMO
Hadassah Medical Center
Novolog
Medison Pharma
Chemipal Group
Dele Health Tech As
China-Israel Biological Technology Co
Noya Therapeutics
American Ortho
Grindeks
Gilead Sciences Israel
Innovestgenetics – IVG
Lexington Medical
Pregnantech
Chengdu Kanghong Pharmaceutical Co
OBCTCD 24
Pluristem
Elcam Medical
CartiHeal (2009)
The Trendlines Group
Elron Electronic Industries
Alon Medtech Ventures
BeyeOnics Surgical
OrthoSpin
NovoCure (Israel)
Technion Research and Development Foundation
Technion Investment Opportunities Fund
Ancora Medical
ApiFix
The Israeli Institute of Biology Research
Compugen
DiA Imaging Analysis
Ballet Vision
Emulait Inc
Clalit Health Services
Pi-Cardia
Ever After Foods
Endymed Medical
Microbot Medical
Clanz Technologies
Pluri Biotech
Rimonci International Specialized Fund
The Kitchen Hub
Unipharm
Be Cure Laser
Leviticus Cardio
Vessi Medical
Vensica Medical
Biontech SE
Jiangsu Aiyimu Medtech Co
Second Skin
Highlight-Mandate
- Advised Sonivie on its USD600 million acquisition by Boston Scientific.
- Advising Pi-Cardia on the negotiation and execution of multi-centre, international clinical trial agreements for its ShortCut and Leaflex studies (across sites in Europe, the United States, Asia, and Israel).
- Assisted Micro with its collaboration with Emory University to evaluate the future autonomous capabilities of the LIBERTY® Endovascular Robotic Surgical System.
Amit, Pollak, Matalon & Co. Advocates and Notary
Amit, Pollak, Matalon & Co. Advocates and Notary‘s ‘high-quality’ healthcare and life sciences practice acts for pharmaceutical and medical manufacturers, as well as med-tech companies, on a range of transactional, IP and regulatory matters. Yoav Etzyon routinely advises on major transactions involving life sciences and healthcare start-ups; Chagit Pedael has longstanding hi-tech industry expertise; and Ian Rostowsky is an experienced commercial law and corporate deal practitioner.
Praxisleiter:
Ian Rostowsky; Yoav Etzyon
Weitere Kernanwälte:
Stephen Rozen; Sahar Peled; Assaf Baruch; Itamar Cohen
Referenzen
‘Highly professional firm, resolving issues in an easy and peaceful way. Very pleasant to work with.’
‘Good communication skills, and they are on top of the detail and highly involved.’
‘A good team that is cost effective.’
Kernmandanten
Acculine
Arieli Capital
BT Beamedical Technologies
CanNegev
Dali Medical Devices
Dermafence
Earendel Medical
EpiMag Medical Technologies
Epitech MAG
FORE Biotherapeutics
Foresee Genomics
Galmed Pharmaceuticals
Good Energies
Ilumigyn
IM Cannabis Corp
LionBird III
Mashlom.Me – Healthcare Toolbox
Medcase Health
Nano-X Imaging
Newpace
NINA Medical
Novartis Israel
Orsense
Red C Biotech
Scopix
Sealantium Medical
Highlight-Mandate
- Assisting Scopix and Sealantium Medical with their respective IP needs on a multi-jurisdictional basis.
- Advising Novartis Israel on its privacy protection and data processing needs, as well as on software and SaaS deals.
- Advising NINA Medical on a clinical trial agreement with a large academic hospital in Israel.
Barnea Jaffa Lande & Co.
Barnea Jaffa Lande & Co.'s recent experience includes investments in medical and biotechnology start-ups and emerging companies. The team also covers M&A, compliance, IP, clinical trials, pharmaceutical research, and licensing and collaboration agreements Michael Barnea acts for prominent healthcare and life science companies; Ken Shaked is a former Dexcel Pharma in-house counsel; and Ariella Dreyfuss represents medical device companies, entrepreneurs and investors. Pharmaceutical and healthcare sector specialist Efrat Cohen is a February 2025 recruit.
Praxisleiter:
Michael Barnea; Ken Shaked
Weitere Kernanwälte:
Efrat Cohen; Ariella Dreyfuss; Tal Frelich Hai
Referenzen
‘The team possesses vast expertise in various hi-tech and healthcare matters.’
‘They never seem to lose their ambition and passion. Clients view them as true partners and seek their involvement in all critical business and legal decisions.‘
‘Michael Barnea is a man to look up to and learn from.’
Kernmandanten
Clexio Biosciences
MedAware
BioGenCell
Maccabi Healthcare Services
CardiacSense
Predicta Med
Tuttnauer
Lembas
Highlight-Mandate
- Advising Clexio Biosciences on all commercial matters.
- Acting for MedAware, which has developed an AI system to identify medication-related errors and adverse drug events, on commercial matters, including development and licensing agreements.
- Advising BioGenCell, a biotechnology company, on its commercial matters.
Epstein Rosenblum Maoz (ERM)
Epstein Rosenblum Maoz (ERM)‘s healthcare and life sciences team draws on expertise in regulation, intellectual property, corporate and commercial law, and employment, alongside experience in disputes, venture capital investments, M&A and financing transactions within the sector. Ron Abelski‘s track record includes M&A and investment transactions, along with the regulatory aspects of the healthcare and pharmaceutical sectors. Simon Marks advises Israeli and international technology companies, start-ups and investors on life sciences mandates.
Praxisleiter:
Ron Abelski; Simon Marks
Weitere Kernanwälte:
Michal Gazit Molcho
Referenzen
‘Truly exceptional in the way it combines professionalism, accessibility, and a deep understanding of the unique needs of growing brands.’
‘What sets them apart is their ability to cover a wide range of legal areas under one roof – from commercial contracts and trademark protection to IP, manufacturing agreements, employment law, influencer management, and strategic partnerships.’
‘Unlike other firms that often specialise in one area, this practice provides holistic, end-to-end support tailored to the brand’s journey. Another strength is their highly responsive and service-oriented approach.’
Kernmandanten
Fresenius Medical Care Israel
Pitango Venture Capital
3d Innotech
Angel Investors
Neoterra Holdings
Aluma Resilience
QR Genetics
Selfit Medical
MDT – Micro Diamond Technologies
On Clinic Advanced Medical Institutes
Bioxtreme
IQVIA
Happiness Capital
GHF
BVI Medical
Atvisor AI
Hisense
PillTracker
Anacure Medical
Alive HealthTech Fund
Novolog
Tethys Equity
Highlight-Mandate
- Advising Fresenius Medical Care Israel on commercial, regulatory and competition law matters across its Israeli operations.
- Assisting Sarel (a procurement company owned by Israel’s public hospitals) with launching a strategic partnerships programme and its inaugural alliance with Autonomi.
- Advising Hisense on its ongoing commercial agreements, as well as its compliance and privacy regulation work, in connection with the company’s smart baby-monitoring product suite.
Katzenell Dimant
Katzenell Dimant‘s healthcare and life sciences practice boasts experts in regulatory compliance, ethical codes of conduct, protocols, licensing, and data protection and privacy. The Herzliya-based team is also experienced in clinical trials, and interacting with clinical research organisations, hospitals, and academic institutions. Einat Katzenell, who ‘brings a rare mix of technical excellence and commercial pragmatism’, co-leads the group alongside Ran Dimant, Neil Stowe and Eyal Sternberg.
Praxisleiter:
Einat Katzenell; Ran Dimant; Neil Stowe; Eyal Sternberg
Referenzen
‘The healthcare and life sciences practice combines deep sector knowledge with practical, business-focused advice.’
‘What stands out most is their ability to navigate disputes with clarity and precision, ensuring legal protections while always keeping the company’s operational needs in mind.’
‘Their responsiveness, strategic thinking, and ability to coordinate across jurisdictions set them apart from other firms.’
Kernmandanten
Belkin Vision
Bio View
Unbox Ventures
Holon Institute of Technology
BIRAD Bar-Ilan Research & Development Company
Rendiatech
Nanomedic Technologies
G-Medical Innovations
Capital Point
Surgical KIS
ItaiAndBeyond
Partam High-Tech
Anicca
Nayara
Bluespine
Temp-Drop
Highlight-Mandate
- Advised Belkin Vision on a $466m merger transaction with a subsidiary of pharmaceutical Company Alcon.
- Successfully represented Bio View in an attempted hostile takeover attempt.
- Advised Bluespine Technologies on its seed and Series A financing round, as well as its global commercial activities and engagement with strategic partners.
Naschitz, Brandes, Amir & Co.
Naschitz, Brandes, Amir & Co. acts for healthcare and life sciences companies, as well as investors, banks, research institutions, healthcare providers, and other medical ecosystem entities. The practice assists with company formation, fundraising, patent applications, licensing agreements, and M&A. It also covers related capital markets work, IP strategy, employment law, tax, litigation, and privacy and data protection policies. Noga Devecseri Spira is digital health head, while Tamar (Arad) Kareth is medical malpractice leader.
Praxisleiter:
Noga Devecseri Spira; Tamar (Arad) Kareth
Kernmandanten
Leumit Health Services
Padagis Pharmaceuticals Israel
European Innovation Council (EIC) Fund
Healthy.io
New Phase
Rafa Laboratories
National Institutes of Biomedical Innovation, Health And Nutrition, Japan
Arbox
EFA Engineering
MeMed Diagnostics
Telepharma
Leumit Health Services
Novamed
Femi Premium
Bioavenir
Simplivia Healthcare
MDClone
Rafa Laboratories
Simplivia Healthcare
Dr Sari Yahav’s Multidisciplinary Clinic for Orthodontics and Oral Health